tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
ZyVersa Therapeutics reports Q2 EPS (46c) vs. ($3.31) last year
PremiumThe FlyZyVersa Therapeutics reports Q2 EPS (46c) vs. ($3.31) last year
2M ago
ZyVersa Therapeutics expects cash to fund requirements on month-to-month basis
Premium
The Fly
ZyVersa Therapeutics expects cash to fund requirements on month-to-month basis
2M ago
ZyVersa Therapeutics Stock Approved for OTCQB Listing
Premium
Company Announcements
ZyVersa Therapeutics Stock Approved for OTCQB Listing
2M ago
ZyVersa supports FDA-authorized Emergency Compassionate Use of VAR 200
PremiumThe FlyZyVersa supports FDA-authorized Emergency Compassionate Use of VAR 200
3M ago
ZyVersa Therapeutics files to sell 17.5M shares of common stock for holders
Premium
The Fly
ZyVersa Therapeutics files to sell 17.5M shares of common stock for holders
3M ago
ZyVersa announces first clinical site activation in VAR 200 Phase 2a trial
Premium
The Fly
ZyVersa announces first clinical site activation in VAR 200 Phase 2a trial
3M ago
ZyVersa Therapeutics highlights publication of data on IC 100
PremiumThe FlyZyVersa Therapeutics highlights publication of data on IC 100
4M ago
ZyVersa Therapeutics announces developments on inflammasome inhibitors
Premium
The Fly
ZyVersa Therapeutics announces developments on inflammasome inhibitors
5M ago
ZyVersa Therapeutics announces publication of data on inflammasome inhibition
Premium
The Fly
ZyVersa Therapeutics announces publication of data on inflammasome inhibition
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100